Partnerships

Where Us2.ai fits in cardiac care

Us2.ai is vendor-neutral and ships through imaging OEMs, AI platforms, and PACS systems. Academic centres run the research that anchors our clinical evidence.

Selected partners

See the full list, grouped by integration type, below.

Integrations

Where Us2.ai is available

Browse partners by integration type — OEM devices, AI platforms, PACS systems, and distributors.

OEM & device resellers

Bundled with ultrasound device sales

Us2.ai is fully vendor-neutral — the software analyses echocardiographic images regardless of the ultrasound machine or vendor used. The partners below are authorised to provide Us2.ai alongside their device sales.

Fujifilm

GE HealthCare

EchoNous

Canon Medical Systems

AI platforms

Available through the AI platform you already use

AI marketplaces and care-pathway platforms that distribute Us2.ai inside their offering — radiology and cardiology departments can deploy through a single platform alongside other validated AI applications.

deepc

Viz.ai

CARPL

aidoc

TeraRecon

Incepto

Ferrum Health

Microsoft / Nuance

Harrison.ai

PACS system integrations

Reports inside the PACS your team reads in

Us2.ai's structured echo reports show up directly in the cardiology reading workflow you already use.

Infinitt North America

Lenus Health (StormID)

HeartLab

AwareMD (Cerebrum / Well Health)

Merge

Studycast

SARC MedIQ

ScImage

Cimar

Other distributors

Regional distribution partners

Distribution partners that bring Us2.ai's automated echo analysis to specific regions and customer segments.

Brasil Medica

MOD3RN Cloud

PanEcho

Emerging Global Technologies (EGT)

I-MEDIC IMAGING SDN BHD

Edimex

Provicon

Research Highlights

Academic research partners

Independent academic centres run the studies that anchor our clinical evidence base.

Duke University

Research partnership

Multi-year research partnership with Duke on AI-enabled echocardiography software.

Read the announcement

Brigham and Women's Hospital

Cardiac Imaging Core Laboratory

Us2.ai provides AI echo diagnosis support for the Cardiac Imaging Core Laboratory at Brigham and Women's Hospital.

Read the announcement

We're also collaborating with additional partners and institutions that can't currently be named due to confidentiality agreements. Our Clinical Evidence page covers further examples of our collaborative and validation work.

Care Pathway

In the Viz.ai ATTR-CM care pathway

Us2.ai is selected as the AI echo algorithm in disease-specific care pathways for under-diagnosed cardiac conditions.

Viz.ai ATTR-CM care pathway

Cardiac amyloidosis

The AI echo algorithm in the Viz.ai ATTR-CM care pathway — built to catch cardiac amyloidosis earlier and route patients into the right downstream care.

See the cardiac amyloidosis pathway

Become a Partner

Build with Us2.ai

Imaging vendors, platform providers, pharma teams, and academic researchers — if there's a way to work together, get in touch.

Contact our team